Related Experiment Video
Updated: Sep 2, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis
Thibaut Michel1, Camille Martinand-Mari, Françoise Debart
1Laboratoire de Chimie Organique Biomoléculaire de Synthèse, UMR 5625 CNRS-UMII, CC 008, Université Montpellier II, Place Eugène Bataillon, 34095 Montpellier Cedex 05, France.
Abstract:
A potential means to improve the efficacy of steric-blocking antisense oligonucleotides (ON) is to increase their affinity for a target RNA. The grafting of cationic amino groups to the backbone of the ON is one way to achieve this, as it reduces the electrostatic repulsion between the ON and its target. We have examined the duplex stabilising effects of introducing cationic phosphoramidate internucleoside linkages into ON with a non-natural alpha-anomeric configuration. Cationic alpha-ON bound with high affinity to single-stranded DNA and RNA targets. Duplex stabilisation was proportional to the number of cationic modifications, with fully cationic ON having particularly high thermal stability. The average stabilisation was greatly increased at low ionic strength. The duplex formed between cationic alpha-ON and their RNA targets were not substrates for RNase H. The penalty in T(m) inflicted by a single mismatch, however, was high; suggesting that they are well suited as sequence-specific, steric-blocking, antisense agents. Using a well-described target sequence in the internal ribosome entry site of the human hepatitis C virus, we have confirmed this potential in a cell-free translation assay as well as in a whole cell assay. Interestingly, no vectorisation was necessary for the cationic alpha-ON in cell culture.
Insights
Cationic alpha-oligonucleotides (ON) show enhanced binding affinity to RNA targets, improving antisense therapy potential. These modified ON are effective in cell-based assays without needing delivery vectors.
Area of Science:
- Biochemistry
- Molecular Biology
- Oligonucleotide Chemistry
Background:
- Antisense oligonucleotides (ON) are investigated for therapeutic applications.
- Improving ON affinity for target RNA is crucial for enhanced efficacy.
- Cationic modifications can reduce electrostatic repulsion, potentially increasing ON-RNA binding.
Purpose of the Study:
- To evaluate the duplex stabilizing effects of introducing cationic phosphoramidate internucleoside linkages into alpha-anomeric ON.
- To assess the binding affinity and antisense potential of these modified ON against RNA targets.
Main Methods:
- Synthesis of cationic alpha-oligonucleotides with phosphoramidate linkages.
- Analysis of duplex thermal stability with single-stranded DNA and RNA targets.
- Assessment of RNase H substrate activity.
- Evaluation of steric-blocking antisense activity in cell-free and cell-based assays using a Hepatitis C virus target sequence.
Main Results:
- Cationic alpha-ON exhibited high binding affinity to single-stranded DNA and RNA.
- Duplex stabilization increased proportionally with cationic modifications, showing high thermal stability in fully modified ON.
- Stabilization was notably enhanced at low ionic strength.
- The resulting duplexes were not substrates for RNase H, and a single mismatch significantly reduced binding affinity (Tm penalty).
- Effective inhibition of translation was observed in both cell-free and cell-based assays without the need for vectorization.
Conclusions:
- Cationic alpha-ON are effective steric-blocking antisense agents with high affinity and sequence specificity.
- These modifications significantly enhance duplex stability, particularly at low ionic strengths.
- The demonstrated efficacy in cell culture without vectorization highlights their therapeutic potential for antisense applications.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Viruses with RNA Genomes
Hepatitis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

